Stocksigma LogoStocksigma Logo

Chandan Healthcare Expands Integrated Diagnostic Network and Diagnostic Presence

Chandan Healthcare delivered robust Q1FY27 performance, reporting revenue of ₹92.25 crore, EBITDA of ₹20.98 crore (22.75% margin), and PAT of ₹7.50 crore

Chandan Healthcare Expands Integrated Diagnostic Network and Diagnostic Presence

Chandan Healthcare Ltd · Others (Uncategorized) · 25 Sept 2026, 7:57 pm

Chandan Healthcare Expands Integrated Diagnostic Network and Diagnostic Presence Chandan Healthcare delivered robust Q1FY27 performance, reporting revenue of ₹92.25 crore, EBITDA of ₹20.98 crore (22.75% margin), and PAT of ₹7.50 crore (8.13% margin). In FY26, revenue reached ₹270.39 crore with an EBITDA margin of 20.25%, driven by B2C retail (41.50% share, up 29.57% YoY), B2G government partnerships (31.82% share), and B2B institutional segments (26.68% share, up 50.58% YoY). Over the next three years, the company plans to add 40 comprehensive diagnostic centres, 50 diagnostic centres, 50 standalone laboratories, and over 5,000 franchise centres across 17 states.

Original exchange filing (PDF)

More announcements from Chandan Healthcare Ltd

All Chandan Healthcare Ltd announcements